US BANCORP \DE\ - BICYCLE THERAPEUTICS PLC ownership

BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 89 filers reported holding BICYCLE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of BICYCLE THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$6,926
+38.5%
2340.0%0.00%
Q3 2022$5,000
-16.7%
234
-38.9%
0.00%
Q2 2022$6,000
-40.0%
383
+63.7%
0.00%
Q1 2022$10,000
-56.5%
234
-36.9%
0.00%
Q4 2021$23,000
-94.5%
371
-96.3%
0.00%
-100.0%
Q3 2021$416,000
+7.5%
9,989
-21.6%
0.00%0.0%
Q2 2021$387,000
+2.9%
12,741
+1.3%
0.00%0.0%
Q1 2021$376,000
+60.0%
12,574
-3.8%
0.00%0.0%
Q4 2020$235,00013,0730.00%
Other shareholders
BICYCLE THERAPEUTICS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 917,218$40,248,00048.61%
GREAT POINT PARTNERS LLC 550,592$24,160,0005.84%
Logos Global Management LP 950,000$41,686,0005.40%
Deep Track Capital, LP 1,855,993$81,441,0005.22%
First Light Asset Management, LLC 890,174$39,061,0003.44%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 1,154,126$50,643,0003.00%
Ikarian Capital, LLC 478,784$21,009,0002.76%
Opaleye Management Inc. 175,000$7,679,0002.38%
Frazier Life Sciences Management, L.P. 603,521$26,483,0002.26%
Altium Capital Management LP 120,000$5,266,0001.76%
View complete list of BICYCLE THERAPEUTICS PLC shareholders